63870-39-3

Usage

Uses

Used in Pharmaceutical and Chemical Research:
(5-AMINO-1H-1,2,4-TRIAZOL-3-YL)METHANOL is used as a building block for the synthesis of various biologically active compounds, including potential drug candidates. Its unique structure allows for the development of new pharmaceuticals with tailored properties for specific therapeutic applications.
Used in Organic Synthesis:
As a versatile intermediate, (5-AMINO-1H-1,2,4-TRIAZOL-3-YL)METHANOL is used in organic synthesis for the modification and functionalization of the triazole ring. This enables chemists to create a range of compounds with specific properties, suitable for various applications in the chemical industry.
Used in Coordination Chemistry:
(5-AMINO-1H-1,2,4-TRIAZOL-3-YL)METHANOL may also be utilized as a reagent in the preparation of coordination compounds. Its ability to form stable complexes with metal ions makes it a useful component in the development of new materials with applications in areas such as catalysis, sensing, and medicinal chemistry.

InChI:InChI=1/C3H6N4O/c4-3-5-2(1-8)6-7-3/h8H,1H2,(H3,4,5,6,7)

Upstream product

• 79-14-1 glycolic Acid 
• 2582-30-1 aminoguanidine bicarbonate 

Downstream Products

• 54535-00-1 (5,7-dimethyl- [1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methanol 
• 55293-96-4 5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carbaldehyde 

Relevant academic research and scientific papers

INHIBITORS OF HEPATITIS C VIRUS POLYMERASE

The present invention provides, among other things, compounds represented by the general Formula (I) and pharmaceutically acceptable salts thereof, wherein X, Y, R1A, R1B, R2, and R3 are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.

METHODS FOR THE PREPARATION OF HCV POLYMERASE INHIBITORS

The present invention relates to methods and compounds useful in the preparation of compounds of the formula (I).

Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same

The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1 and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.

INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME

The invention relates to compounds of the formula (I) and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula (I), and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula (I). The invention also relates to methods of preparing the compounds of formula (I).